Cath Lab Activation Time an Important Quality Metric for Patients with STEMI Presenting in non-PCI Capable Hospitals
An analysis of a study called Mission: Lifeline STEMI Accelerator II found that when patients experiencing an ST-elevation myocardial infarction present in facilities not capable of performing percutaneous intervention, the time between their arrival and cath lab activation is an important quality metric to direct timely reperfusion.
Duke Hosts Symposium on Addressing Public Health Crises with Data Science
Seven DCRI faculty participated in the June 24 event, which shared a range of Duke research projects and nationwide collaborative efforts geared toward addressing COVID-19 and racial and ethnic health disparities. The Duke University School of Medicine’s Office of Data Science and Information Technology and Duke AI Health partnered to co-host a virtual symposium on Wednesday, June 24, focused on using data science to combat public health crises.
Challenges to Developing and Implementing Integrated Pain Management Programs
DCRI faculty recently contributed to a paper advocating for a focus on pain management so that progress in combatting the U.S. opioid crisis is not lost in the midst of the COVID-19 pandemic.
Splanchnic Nerve Block Effective for Improving Exercise Measures in Patients with Heart Failure
Study results recently published in the Journal of the American College of Cardiology: Heart Failure build on novel research investigating the efficacy of blocking the splanchnic nerve to treat patients with heart failure. The study, which was led by former DCRI fellow Marat Fudim, MD, MHS, included 15 patients who underwent a temporary medication-induced splanchnic nerve blockage and required them to complete an exercise twice—once prior to the blockage, and once after the blockage.
DCRI Study Provides Insight into Re-operation After Transcatheter Valve Replacement
Although valve failure is rare, patients who had to undergo re-operation were at risk of negative outcomes.
Editorial Shares Takeaways from Recent Deprescribing Study
The DCRI’s Eric Peterson, MD, MHS, recently reviewed an important study in JAMA examining novel strategies to de-escalate hypertension treatment in older adults.
DCRI Studies Lead To Greater Knowledge about Video Gaming as an ADHD Treatment
The FDA recently made a precedent-setting decision—for the first time, a video game can be marketed and prescribed as a therapeutic. EndeavorRx, a digital therapeutic created by Akili Interactive Labs, is a video game designed to improve attention in children ages 8 to 12 who have been diagnosed with attention-deficit hyperactivity disorder (ADHD).
Hernandez Talks HCQ Retractions, HERO Research
Adrian Hernandez, MD, MHS, DCRI’s executive director, spoke to Zubin Damania, MD, on his internet show that reaches millions of healthcare professionals and other viewers each week.
The Rise of Telehealth During COVID-19
Two DCRI fellows, one former and one current, recently contributed to a paper published in Journal of the American Medical Informatics Association on the role telehealth has played in U.S. health care during the COVID-19 pandemic. The paper, for which DCRI cardiology fellow Jedrek Wosik, MD, is the corresponding author, details how telehealth has transformed both within the Duke Health system and beyond through the collaboration of people, processes, and technology. The paper focuses on three distinct phases of the crisis caused by the novel coronavirus: outpatient care during the stay-at-home orders, the initial COVID-19 hospital surge, and recovery post-pandemic.
PTN, CTTI Partner on Study, Identify Risk Factors for Hospital-Acquired Pneumonia
The study team used pediatric patients’ electronic health records to identify patients eligible for the study.